Nephrotic Syndrome: Minimal Change Disease and Focal Segmental Glomerulosclerosis

被引：0

作者：

Huber T.B. ^{[1
]}

Grünewald J.F. ^{[1
]}

机构：

[1] Department Innere Medizin, Klinik für Nephrologie und Allgemeinmedizin, Universitätsklinikum Freiburg, Hugstetter Str. 55, Freiburg

来源：

Der Nephrologe | 2016年 / 11卷 / 2期

关键词：

Focal segmental glomerulosclerosis; Minimal change disease; Nephrotic syndrome; Podocyte; Renal insuffciency;

D O I：

10.1007/s11560-015-0018-1

中图分类号：

学科分类号：

摘要：

Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are histopathologically defined podocytopathies which are clinically manifested as nephrotic syndrome. While MCD is most commonly seen in children and usually exhibits a benign clinical course, FSGS has a higher prevalence in adult patients and often leads to a deterioration of renal function possibly resulting in end-stage renal disease. Primary and secondary FSGS differ substantially concerning etiology, clinical presentation and therapy [1, 2]. New hypotheses have been established in recent years regarding the pathogenesis of MCD and FSGS but have not yet been incorporated into clinical diagnostics. However, these insights might translate into a better understanding of these diseases in the long run and possibly contribute to new therapeutic approaches. © 2015, Springer-Verlag Berlin Heidelberg.

引用

页码：106 / 115

页数：9

共 40 条

[1]

Hogan J., Radhakrishnan J., The treatment of minimal change disease in adults, J Am Soc Nephrol, 24, 5, pp. 702-711, (2013)

[2]

D'Agati V., Kaskel F.J., Falk R.J., Focal segmental glomerulosclerosis, N Engl J Med, 365, 25, pp. 2398-2411, (2011)

[3]

Orth S.R., Ritz E., The Nephrotic Syndrome, N Engl J Med, 338, 17, pp. 1202-1211, (1998)

[4]

Wiggins R.C., The spectrum of podocytopathies: a unifying view of glomerular diseases, Kidney Int, 71, 12, pp. 1205-1214, (2007)

[5]

Kang H.G., Cheong H., Il. Nephrotic syndrome: what’s new, what’s hot?, Korean J Pediatr, 58, 8, pp. 275-282, (2015)

[6]

Meyrier A.Y., Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?, Kidney Int, 76, 5, pp. 487-491, (2009)

[7]

Glassock R.J., Secondary minimal change disease, Nephrol Dial Transplant, 18, pp. vi52-i58, (2003)

[8]

Abdel-Hafez M., Shimada M., Lee P.Y., Johnson R.J., Garin E.H., Idiopathic nephrotic syndrome and atopy: is there a common link?, Am J Kidney Dis, 54, 5, pp. 945-953, (2010)

[9]

Bertelli R., Bonanni A., Di Donato A., Cioni M., Ravani P., Ghiggeri G.M., Regulatory T cells and minimal change nephropathy: in the mid of a complex network, Clin Exp Immunol, (2015)

[10]

Lai K.-W., Wei C.-L., Tan L.-K., Et al., Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats, J Am Soc Nephrol, 18, 5, pp. 1476-1485, (2007)

← 1 2 3 4 →